Studies on human colon cancer cell lines show decreased levels of cGMP and elevated levels of PDE5 mRNA [3, 14], indicating a perturbed activity of the PDEs involved in degrading cGMP in CRC. The gene discussed is PDE5A; the disease is colonic neoplasm.